Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


CDER Pharmaceutical Quality Office Gains Permanent Director

This article was originally published in The Pink Sheet Daily

Executive Summary

Former Novartis exec to join FDA in November.


Related Content

US Office Of New Drugs Revamp Taking Shape: More Review Divisions Coming, But Who Will Lead Them?
Inspection Delays Remain For Novel Approvals By US FDA; Will Quality Office Help?
CDER’s 50 Open Leadership Posts Could Be Bigger Hiring Challenges After Trump Freeze
FDA Drug Policy Office Reshuffled Over ‘Spousal Employment’ Conflict
CBER Director Midthun Retiring; Legacy Includes Biosimilar Principles, Avastin Withdrawal
FDA Generics Director’s Departure Shows Why Chemistry Matters
FDA Resurrects Park Doctrine in Enforcement of Pharmaceutical GMPs


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts